Today, most research evaluation frameworks are designed to assess mature projects with well-defined data and clearly articulated outcomes. Yet, few, if any, are equipped to evaluate the promise of early-stage research, which is inherently characterized by limited evidence, high uncertainty, and evolving objectives. These early-stage projects require nuanced assessments that can adapt to incomplete information, project maturity, and shifting research questions. Compounding these challenges is the difficulty of systematically scaling evaluations with the increasing volume of research projects. As a step toward addressing this gap, we introduce the Early-Stage Research Assessment Framework for Artificial Intelligence (ERAF-AI), a systematic approach to evaluate research at Technology Readiness Levels (TRLs) 1 to 3 - maturity levels where ideas are more conceptual and only preliminary evidence exists to indicate potential viability. By leveraging AI-driven methodologies and platforms such as Lateral's Coordination.Network, ERAF-AI ensures transparent, scalable, and context-sensitive evaluations that integrate research maturity classification, adaptive scoring, and strategic decision-making. Importantly, ERAF-AI aligns criteria with the unique demands of early-stage research, guiding evaluation through the 4P framework (Promote, Pause, Pivot, Perish) to inform next steps. As an initial demonstration of its potential, we apply ERAF-AI to a high-impact early-stage project, providing actionable insights and measurable improvement over conventional practices. Although ERAF-AI shows significant promise in improving the prioritization of early-stage research, further refinement and validation across a wider range of disciplines and datasets is required to refine its scalability and adaptability. Overall, we expect this framework to serve as a valuable tool for empowering researchers to make informed decisions and to prioritize high-potential initiatives in the face of uncertainty and limited data.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11760726PMC
http://dx.doi.org/10.1101/2025.01.08.631843DOI Listing

Publication Analysis

Top Keywords

early-stage assessment
8
assessment framework
8
framework artificial
8
artificial intelligence
8
early-stage
7
eraf-ai
5
developing eraf-ai
4
eraf-ai early-stage
4
framework
4
intelligence today
4

Similar Publications

The potential benefits of pyrotinib for patients with trastuzumab-insensitive, HER2-positive early-stage breast cancer remain unclear. This prospective, multicentre, response-adapted study evaluated the efficacy and safety of adding pyrotinib to the neoadjuvant treatment of HER2-positive breast cancer patients with a poor response to initial docetaxel plus carboplatin and trastuzumab (TCbH). Early response was assessed using magnetic resonance imaging (MRI) after two cycles of treatment.

View Article and Find Full Text PDF

Background: Multifrequency MR elastography (mMRE) enables noninvasive quantification of renal stiffness in patients with chronic kidney disease (CKD). Manual segmentation of the kidneys on mMRE is time-consuming and prone to increased interobserver variability.

Purpose: To evaluate the performance of mMRE combined with automatic segmentation in assessing CKD severity.

View Article and Find Full Text PDF

Hospital mergers have increased significantly since 2010, driven by factors such as healthcare policy changes, reimbursement, economies of scale, and quality improvement goals. However, limited evidence exists about how these mergers affect the quality of care and cancer outcomes. We conducted a difference-in-differences analysis to assess the impact of hospital consolidation on cancer outcomes.

View Article and Find Full Text PDF

Purpose: This study evaluates the feasibility of utilizing robotic-assisted bronchoscopy with cone beam computed tomography (RB-CBCT) platform to perform low-dose-rate brachytherapy implants (LDR-BT) in a mechanically ventilated human cadaveric model. Post-implant dosimetry was compared to standard stereotactic body radiation therapy plans (SBRT).

Materials And Methods: The RB-CBCT platform was used to place inert LDR-BT seeds into mechanically ventilated human cadavers with percutaneously injected pseudotumors.

View Article and Find Full Text PDF

Aim: To explore the trajectories of consciousness recovery and prognosis-associated predictors in children with prolonged disorder of consciousness (pDoC).

Method: This single-centre, retrospective, observational cohort involved 134 (87 males, 47 females) children diagnosed with pDoC and hospitalized at the Department of Rehabilitation at the Children's Hospital of Chongqing Medical University in China. The median onset age was 30 (interquartile range [IQR] 18-54) months, with onset ages ranging from 3 to 164 months.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!